Agf Investments LLC Alnylam Pharmaceuticals, Inc. Transaction History

Agf Investments LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $654,362 - $919,921	-5,434 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$127.18 - $173.91 $691,096 - $945,026	5,434 New	5,434 $887,000
Q2 2021 Aug 12, 2021	SELL	$128.63 - $176.89 $531,499 - $730,909	-4,132 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $250,996 - $347,690	-1,979 Reduced 32.38%	4,132 $583,000
Q4 2020 Feb 08, 2021	SELL	$122.97 - $147.0 $519,671 - $621,222	-4,226 Reduced 40.88%	6,111 $794,000
Q3 2020 Nov 12, 2020	BUY	$121.19 - $165.49 $124,462 - $169,958	1,027 Added 11.03%	10,337 $1.51 Million
Q2 2020 Aug 11, 2020	BUY	$104.21 - $156.44 $963,525 - $1.45 Million	9,246 Added 14446.88%	9,310 $1.38 Million
Q1 2020 May 08, 2020	BUY	$93.12 - $133.99 $5,959 - $8,575	64 New	64 $7,000
Q2 2018 Aug 13, 2018	SELL	$88.31 - $107.8 $23,137 - $28,243	-262 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$115.92 - $148.54 $12,287 - $15,745	106 Added 67.95%	262 $24,000
Q4 2017 Feb 07, 2018	BUY	$114.49 - $139.98 $8,014 - $9,798	70 Added 81.4%	156 $20,000
Q3 2017 Nov 09, 2017	BUY	$72.53 - $118.27 $6,237 - $10,171	86	86 $11,000

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.